Clinical Trials—eSVS Mesh
The U.S. Food and Drug Administration (FDA) has approved an Investigation Device Exemption (IDE) allowing Kips Bay to conduct a feasibility trial of the eSVS Mesh. We are working with some of the leading cardiac research centers in the United States and Europe.
US Centers
Cleveland Clinic
Cleveland, OH
Cleveland, OH
Emory University Hospital Heart and Vascular Center
Atlanta, GA
Atlanta, GA
Lennox Hill Hospital
New York, NY
New York, NY
The Mayo Clinic
Rochester, MN
Rochester, MN
Northeast Georgia Medical Center, The Heart Center
Gainesville, GA
Gainesville, GA
Texas Heart Institute
Houston, TX
Houston, TX
International Centers
Catharina-Ziekenhuis
Eindhoven, Netherlands
Eindhoven, Netherlands
Centre Hospitalier Universitaire de Limoges
Limoges, France
Limoges, France
Fondazione Toscana G. Monasterio, Ospedale Pasquinucci
Massa, Italy
Massa, Italy
Hôpital Cardiologique de Haut Lévèque
Pessac, France
Pessac, France
Inselspital, Universitätsspital Bern
Bern, Switzerland
Bern, Switzerland
Lancisi Hospital – Ospedali Riuniti di Ancona
Ancona, Italy
Ancona, Italy
Medical University of Vienna
Vienna, Austria
Vienna, Austria
Royal Brompton Hospital
London, United Kingdom
London, United Kingdom